Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -1.64% inched 0.48% higher to $166.09 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.91% rising 0.40% to 4,297.14 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.06% rising 0.45% to 33,912.44. The stock's rise snapped a two-day losing streak. Johnson & Johnson closed $20.60 below its 52-week high ($186.69), which the company reached on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +4.49% rose 3.96% to $336.40, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.97% fell 0.46% to $90.60, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -2.29% fell 0.72% to $49.75. Trading volume (10.0 M) eclipsed its 50-day average volume of 6.7 M.